Edgewise Therapeutics, Inc. (EWTX) Earnings
|
Expand Research on EWTX
| Next EPS Date | 8/6/26 | EPS Growth Rate | -41.2% |
|---|---|---|---|
| Average EPS % Beat Rate | +5.2% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +2.7% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/6/26  |
Q226 | N/A | -$0.48 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/7/26 | Q126 | -$0.46 | -$0.49 | +$0.03 | N/A | N/A | N/A |  | | Details | |
| 2/26/26 | Q425 | -$0.47 | -$0.44 | -$0.03 | N/A | N/A | N/A | | | Details | |
| 2/24/26 |
Q425 | N/A | -$0.44 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 2/23/26 |
Q425 | N/A | -$0.44 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 2/20/26 |
Q425 | N/A | -$0.44 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 2/19/26 |
Q425 | N/A | -$0.44 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/6/25 | Q325 | -$0.39 | -$0.40 | +$0.01 | N/A | N/A | N/A | | | Details |
